Objectives: To analyze the procedural and long-term outcomes of the use of rotational atherectomy (RA) in underexpanded stents in our cohort and to provide an overview of currently available data on this technique.
| INTRODUCTION
Calcified coronary lesions are very common in contemporary interventional practice. The real prevalence is unknown, but a study showed its occurrence in 38% of all lesions evaluated by angiography and in 74% of cases when intravascular ultrasound was used. 1 Additionally, considering the aging of the population and the expansion of percutaneous coronary intervention indications, an increase in calcified lesions incidence is expected. 2 Severely calcified lesions are challenging to deal with, and noncompliant or cutting-balloons may not be sufficient to prepare the plaque correctly prior stent implantation. Rotational atherectomy (RA) has been used as an alternative to manage undilatable calcified lesions, usually before stent deployment with good long-term results. 3 Overlooking a calcified lesion or the need of a rapid stent implantation in case of clinical instability can lead to a sub-optimal plaque preparation and subsequent stent underexpansion (SU). 4 Reports have shown that SU was related to stent thrombosis and restenosis. 5, 6 Stentablation, meaning the use of RA to treat SU, has been used as a bail-out strategy with encouraging results. 4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Nevertheless, data about the long-term clinical outcomes of this approach are limited to a few case reports and two recently published series. 17, 18 Our purpose was to analyze the procedural and long-term impact of RA as an alternative strategy to ablate underexpanded stents in our population, and to provide a summary of the related data currently available 2 | MATERIALS AND METHODS
| Study population
Between January 2013 and July 2017, a total of 1078 patients were treated with RA at the Rangueil University Hospital, Toulouse, France.
Patients with in-stent restenosis were excluded, and 11 patients (1.02%) requiring stent ablation were selected. Revascularization was indicated in acute coronary syndromes (ACS) and was either clinically driven, or ischemia driven in case of effort angina. All patients signed an informed consent form for the procedures and usage of their anonymized data for research purposes. The Institution Ethics
Committee from our center approved the study.
| Procedure and follow-up
The procedures were performed by experienced operators in RA.
Stentablation was performed when a "dogbone effect" was observed following a failure to expand the stent correctly, despite several dilatations with non-compliant balloons. RotaLink™ Plus system (Boston Scientific, Marlborough, MA) and a standard, 0.009 inch guidewire (RotaWire™; Boston Scientific) were used to perform RA, as reported. 2 Rotational speed was set between 150 000 and 180 000 rpm and all ablation times were inferior to 15 s to prevent a risk of thrombosis due to excessive thermal injury. Patients were pretreated with dual-antiplatelet therapy before the procedure and the treatment was pursued for at least 6 months after the procedure. The decision to further maintain antiplatelet therapy was at discretion of their treating physicians. Optimal medical treatment was achieved during hospitalization.
Baseline characteristics, procedural data, and clinical outcomes at follow-up were collected retrospectively and compiled in a database.
In case of missing information in the electronic medical records, we contacted the patientś primary care physicians, or contacted the patients directly in order to obtain complete sets of clinical data.
| Definitions and endpoints
Procedural success was defined as the correct RA of the underexpanded stent and the successful delivery of an adequately apposed stent with a residual stenosis <30%. 3 | RESULTS and nearly half of patients were admitted in the context of an ACS (45.5%).
The procedural characteristics are presented in Table 2 and an example of patient treated with stentablation is displayed on No surgical intervention was conducted for any of the patients, no rhythm disturbances requiring atropine and no indications for pacemaker implantation were identified.
In-hospital and long-term outcomes are presented in Table 3 . No in-hospital deaths or MACE were documented. During hospitalization, two patients required a punctual renal replacement therapy with posterior stabilization of initial renal function (Baseline glomerular filtration rate 16 and 22 mL/min, respectively). One of these cases, also required a red blood cells transfusion due to gastrointestinal bleeding.
Median follow up time was 26 months . No deaths were documented. Only one patient (9.1%) had a MACE. He was admitted 
| DISCUSSION
The main findings of the present study can be summarized as follows: Reported procedural success with this device ranges from 84% to 96%
and mid-term outcomes are also acceptable. 23, 24 However, a lack of experience and the limited availability of this technique in numerous centers restrain its widespread use.
Quang et al performed stentablation in a porcine model using microscopy and X-ray mammography to analyze the deposit of pulverized metal particles in the myocardium. They found that over 95% of these particles measured less than 15 μm suggesting that they were small enough to be removed by the reticuloendothelial system. Various mechanisms have been proposed to explain the facilitation of expansion of the stent. The most plausible of them seems to be heat generation leading to liquefaction of the calcified atheroma behind the stent struts that would facilitate the balloon expansion. 18, 26, 27 Other possible cause may be the direct ablation of the metallic stent and fibrocalcific tissue. 8 Previous reports on stentablation are summarized in Table 4 Recently, two new series of cases were reported in the literature:
Édes et al published a study on the outcomes of 12 patients. They described a high rate of procedural success without any in-hospital MACE nor mortality, as found in our analysis. However, a 6-month follow-up revealed that 50% of the patients had a MACE and 25% of them were dead. These different follow-up results could be explained by a higher rate of diabetic and prior coronary artery bypass surgery patients compared to our population.
In contrast, Ferri et al reported more favorable outcomes at one-year follow-up with a 26.6% rate of MACE and 13.3% of TLR. Acute procedural results were also favorable despite isolated complications such as coronary dissection and burr entrapment that were correctly solved. More than half of the patients were studied with intravascular ultrasound. 18 The present paper brings more evidence of the benefits of RA as a treatment strategy of under expanded stents and supports favorable long-term outcomes. Moreover, we describe the first "scaffold-ablation" with positive results. Procedural complication rates were similar among the three working groups and were included into the expected rate of complex coronary interventions. Also, when feared complications such as coronary artery dissection, perforation, and burr entrapment presented, the three interventional groups were able to manage them percutaneously without surgical intervention.
We strongly recommend performing a careful plaque preparation before stenting in order to avoid stent underexpansion in severe CCL. Indeed, the use of intravascular ultrasound can help identify a CCL hardly detectable in angiography. Nevertheless, when SU is present, the use of stent ablation seems to be a valuable bail-out At last, additional data about long-term outcomes are needed.
While future randomized trials are not likely, larger multicenter registries would confirm these findings. 
| Limitations
This study was small, single center, and retrospective. No intravascular images were used in any of the patients. Angiographic follow-up was available only in half of the patients. However, the other half of them were evaluated in a non-invasive manner or clinically driven, and the main objective of this study was to evaluate safety and long-term clinical outcomes.
| CONCLUSION
RA of underexpanded stents is a feasible option with a high rate of procedural success as a bail-out strategy. At long-term follow-up, 90.9%
of patients remained free from MACE and all of them were alive. Further analysis in multicenter registries are required to confirm these findings.
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